Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an
HbA1c
< 7%, without weight gain or hypoglycaemia, over 52 weeks
2012 ◽
Vol 15
(3)
◽
pp. 264-271
◽
2011 ◽
Vol 36
(7)
◽
pp. 999-1006
◽
Keyword(s):
2012 ◽
Vol 125
(11)
◽
pp. 1381-1389
◽
Keyword(s):
Keyword(s):